Navidea Biopharmaceuticals Inc (NAVB)
0.0376
0.00 (0.00%)
USD |
OTCM |
Apr 25, 16:00
Navidea Biopharmaceuticals Revenue (TTM)
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2021 | 0.0456M |
| September 30, 2021 | 0.1325M |
| June 30, 2021 | 0.1301M |
| March 31, 2021 | 0.126M |
| December 31, 2020 | 0.1187M |
| September 30, 2020 | 0.0336M |
| June 30, 2020 | 0.0317M |
| March 31, 2020 | 0.0387M |
| December 31, 2019 | 0.0266M |
| September 30, 2019 | 0.059M |
| June 30, 2019 | 0.0764M |
| March 31, 2019 | 0.3249M |
| December 31, 2018 | 0.3225M |
| September 30, 2018 | 0.2966M |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | 1.835M |
| September 30, 2016 | -3.863M |
| June 30, 2016 | -1.708M |
| March 31, 2016 | -0.0076M |
| December 31, 2015 | 1.152M |
| Date | Value |
|---|---|
| September 30, 2015 | 11.15M |
| June 30, 2015 | 9.425M |
| March 31, 2015 | 7.632M |
| December 31, 2014 | 6.275M |
| September 30, 2014 | 4.612M |
| June 30, 2014 | 2.762M |
| March 31, 2014 | 1.882M |
| December 31, 2013 | |
| September 30, 2013 | |
| June 30, 2013 | |
| March 31, 2013 | |
| December 31, 2012 | |
| September 30, 2012 | |
| June 30, 2012 | |
| March 31, 2012 | |
| December 31, 2011 | |
| September 30, 2011 | 1.066M |
| June 30, 2011 | 0.9595M |
| March 31, 2011 | 3.492M |
| December 31, 2010 | 5.839M |
| September 30, 2010 | 7.816M |
| June 30, 2010 | 10.25M |
| March 31, 2010 | 9.519M |
| December 31, 2009 | 9.518M |
| September 30, 2009 | 8.825M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
0.0266M
Minimum
Dec 2019
0.1325M
Maximum
Sep 2021
0.0744M
Average
0.059M
Median
Sep 2019
Revenue (TTM) Benchmarks
| Perspective Therapeutics Inc | 0.00 |
| Electromed Inc | 51.69M |
| Xtant Medical Holdings Inc | 91.30M |
| Asensus Surgical Inc | 8.577M |
| Senseonics Holdings Inc | 22.39M |